NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-07-30 17:23இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
22.2% Revenue Growth in Q1 FY27; PAT Declines 40.5% Amid Margin Compression
Mangalam Organics reported a strong 22.2% YoY revenue growth to ₹179.09 Cr for Q1 FY27, driven by its expanding retail presence. However, Net Profit (PAT) fell significantly by 40.5% YoY to ₹7.27 Cr as EBITDA margins contracted from 14.74% to 12.40%. The decline is primarily attributed to a 50.5% surge in raw material costs, which reached ₹122.89 Cr during the quarter. While the company is successfully pivoting to a B2C model (now 38% of revenue), high debt levels of ₹356 Cr remain a concern relative to its ₹449 Cr market cap.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company released its Q1 FY27 investor presentation, revealing a divergence between strong top-line growth and declining profitability due to input cost pressures.
ஏன் இது முக்கியம்The results demonstrate the execution of the company's B2C strategy (38% revenue share) but also highlight its continued vulnerability to volatile global raw material prices and high leverage.
📅 குறுகிய காலம்The stock may face pressure in the short term as the market digests the 40% drop in quarterly profit and the impact of rising input costs on margins.
📈 நீண்ட காலம்The structural shift toward branded retail (B2C) is positive for long-term valuation, but sustainable growth depends on managing high debt and reducing sensitivity to camphor price cycles.
⚠ அபாய எச்சரிக்கைகள்
High raw material price volatility (60-70% of costs)
High Debt-to-Equity ratio (>1.1x)
Significant import dependency for key inputs
👀 கவனிக்க வேண்டியவை
Investors should monitor the stabilization of raw material prices (Alpha pine and gum turpentine) and the company's ability to pass on costs through its branded retail segment. Watch for debt reduction progress in upcoming quarters as interest costs (₹7.42 Cr in Q1) are consuming a significant portion of EBIT.
Q1 Revenue up 22% to ₹179 Cr; Net Profit Declines 40% YoY on Higher Input Costs
Mangalam Organics reported a 22.2% YoY increase in consolidated revenue to ₹179.09 Cr for Q1 FY27. However, net profit fell 40.6% to ₹7.27 Cr compared to ₹12.23 Cr in Q1 FY26, primarily due to a sharp rise in raw material costs which reached ₹122.89 Cr. The company also proposed the appointment of JMT & Associates as new statutory auditors for a five-year term. The 44th Annual General Meeting is scheduled for September 24, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company reported its Q1 FY27 financial results showing strong top-line growth but significant margin compression, alongside a planned transition in statutory auditors.
ஏன் இது முக்கியம்The results highlight the company's vulnerability to volatile raw material costs, which offset the benefits of higher sales volumes and capacity utilization.
📅 குறுகிய காலம்The stock may face pressure in the short term as the market reacts to the 40% drop in net profit despite the revenue growth.
📈 நீண்ட காலம்Long-term performance depends on the successful scaling of the higher-margin retail FMCG portfolio (currently 38% of revenue) to mitigate raw material price volatility.
⚠ அபாய எச்சரிக்கைகள்
High raw material price volatility
Significant import dependency (60-70% of RM)
High debt-to-equity ratio (0.94)
👀 கவனிக்க வேண்டியவை
Monitor the stabilization of raw material prices (Alpha pine and gum turpentine) and the company's ability to pass on costs through its retail brands like Mangalam and CamPure.
CRISIL Reaffirms BBB+/Stable Rating for Rs 397 Cr Facilities, Removes 'Watch' Status
CRISIL Ratings has removed Mangalam Organics from 'Rating Watch with Developing Implications' and assigned a 'Stable' outlook, reaffirming its Long-Term rating at BBB+ and Short-Term at A2. The review covered bank facilities totaling Rs 397 Crore, which is significant given the company's current debt of Rs 285 Crore and Net Worth of Rs 304 Crore (D/E of 0.94). Additionally, its material subsidiary, Mangalam Brands Private Limited, received a first-time rating of BBB+/Stable for Rs 80 Crore in facilities, signaling credit support for its retail expansion strategy.
உச்சம் நம்பிக்கை
என்ன மாறியதுCRISIL has finalized its credit view on the company, moving from a 'Developing' watch to a 'Stable' outlook and reaffirming existing investment-grade ratings.
ஏன் இது முக்கியம்The removal of the 'Watch' status reduces perceived credit risk for lenders and investors. This is vital for a company with high raw material price sensitivity and significant debt-funded working capital needs.
Total Rated Bank Facilities: Rs 397 CroreSubsidiary Rated Facilities: Rs 80 CroreRated Facilities vs Net Worth: ~130%Long-Term Rating: CRISIL BBB+/StableShort-Term Rating: CRISIL A2
📅 குறுகிய காலம்The removal of the 'Watch' status provides immediate relief regarding credit stability and may support the stock price as it reduces uncertainty regarding bank facility renewals.
📈 நீண்ட காலம்The stable rating supports the company's long-term strategy of diversifying into FMCG (38% of current revenue) and managing its high debt-to-equity position amidst volatile raw material costs.
⚠ அபாய எச்சரிக்கைகள்
High Debt-to-Equity ratio (0.94)
Raw material price volatility (60-70% of costs)
High import dependency for key inputs
👀 கவனிக்க வேண்டியவை
Investors should monitor if this credit stabilization leads to a reduction in finance costs, which is critical given the company's 0.94 D/E ratio. Watch for the execution of the retail strategy in the Mangalam Brands subsidiary, as it now has independent credit access.
Mangalam Organics Appoints Manoj Mhapadi as CFO; Names New Auditors for FY 2026-27
Mangalam Organics has announced a planned leadership transition as CFO Shrirang V. Rajule retires on June 30, 2026, after over two decades with the company. He will be succeeded by Manoj Mhapadi, a Chartered Accountant with 20 years of experience, including 10 years as the company's Head of Finance. Additionally, the board has appointed Vilaskumar Vaghela as Internal Auditor and M/s NKJ & Associates as Cost Auditors for the 2026-27 financial year. These appointments aim to maintain continuity in financial management and regulatory compliance.
முக்கிய அம்சங்கள்
Mr. Manoj Mhapadi appointed as Chief Financial Officer effective July 01, 2026.Outgoing CFO Mr. Shrirang V. Rajule retires on June 30, 2026, after a 20-year tenure.New CFO Manoj Mhapadi has served as the company's Head of Finance for the last 10 years.Mr. Vilaskumar Vaghela and M/s NKJ & Associates appointed as Internal and Cost Auditors respectively for FY 2026-27.
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine and well-planned succession; the internal promotion of the Head of Finance to CFO suggests stability in the company's financial operations.
Mangalam Organics Appoints Manoj Mhapadi as CFO; Shrirang Rajule Retires After 20 Years
Mangalam Organics has announced a planned leadership transition where Mr. Manoj Mhapadi will take over as Chief Financial Officer effective July 1, 2026. This follows the retirement of Mr. Shrirang V. Rajule, who served the company for over two decades. Mr. Mhapadi is an internal promotee with 10 years of experience as the company's Head of Finance and 20 years of total experience as a Chartered Accountant. Additionally, the company has appointed new Internal and Cost Auditors for the 2026-27 financial year to ensure regulatory compliance.
முக்கிய அம்சங்கள்
Mr. Manoj Mhapadi appointed as CFO and KMP effective July 1, 2026.Outgoing CFO Mr. Shrirang V. Rajule retires on June 30, 2026, after more than 20 years with the firm.New CFO Manoj Mhapadi has been with the company for 10 years as Head of Finance, ensuring management continuity.Mr. Vilaskumar Vaghela (Internal Auditor) and M/s. NKJ & Associates (Cost Auditor) appointed for FY 2026-27.The transition includes the handover of Deputy Nodal Officer duties for IEPF matters to the new CFO.
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine and stable succession. The internal promotion of a long-term finance head suggests continuity in financial reporting and strategy.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Mangalam Organics FY26 PAT Surges 103% to ₹25.38 Cr; EBITDA Margins Expand to 14.11%
Mangalam Organics reported a robust financial performance for the fiscal year ended March 2026, with revenue growing 17.46% to ₹622.57 crore. The company's profitability saw a significant boost as PAT doubled to ₹25.38 crore, driven by lower input costs and enhanced operational efficiencies. EBITDA margins improved by 306 basis points YoY to reach 14.11%. Additionally, the company successfully completed its capacity expansion for Bhimseni/Isoborneol Flakes to 2,500 MT per annum during the year.
முக்கிய அம்சங்கள்
Annual Revenue increased by 17.46% YoY to ₹622.57 crore in FY26 compared to ₹530.01 crore in FY25.Net Profit (PAT) grew by 103.04% YoY to ₹25.38 crore, with PAT margins improving from 2.36% to 4.08%.EBITDA rose 49.91% YoY to ₹87.82 crore, reflecting significant improvements in cost management.Successfully completed expansion of Bhimseni/Isoborneol Flakes manufacturing capacity to 2,500 MTPA.Q4 FY26 PAT grew 29.49% sequentially to ₹5.62 crore despite a 6.49% QoQ dip in revenue.
👀 கவனிக்க வேண்டியவை
The doubling of profits and significant margin expansion suggest a strong turnaround and improved cost control. Investors should monitor the ramp-up of the new Bhimseni capacity and the sustainability of raw material price benefits in upcoming quarters.
Mangalam Organics FY26 Net Profit Jumps 75% to ₹13.27 Cr; Revenue Hits ₹500 Cr
Mangalam Organics reported a strong financial performance for the fiscal year ended March 31, 2026, with standalone revenue from operations growing 22% to ₹500.85 crore. Net profit for the full year surged by 74.6% to ₹13.27 crore, up from ₹7.60 crore in the previous year, despite an exceptional loss of ₹3.51 crore. The fourth quarter showed significant momentum with revenue of ₹134.64 crore, representing a 29.5% growth over Q4 FY25. Earnings per share (EPS) saw a substantial increase to ₹15.50 from ₹8.87 YoY.
முக்கிய அம்சங்கள்
Annual revenue from operations increased 22% YoY to ₹500.85 crore in FY26.Full-year net profit grew by 74.6% to ₹13.27 crore compared to ₹7.60 crore in FY25.Q4 FY26 revenue stood at ₹134.64 crore, a 29.5% increase over ₹103.97 crore in Q4 FY25.Earnings Per Share (EPS) expanded significantly to ₹15.50 from ₹8.87 in the previous fiscal.Operating profit before tax for FY26 reached ₹17.72 crore despite a ₹3.51 crore exceptional item loss.
👀 கவனிக்க வேண்டியவை
The company demonstrates robust top-line growth and significant margin expansion, making it a positive outlook for long-term investors. Shareholders should monitor the impact of raw material costs and the nature of the negative other income reported in the final quarter.
CRISIL Reaffirms Mangalam Organics Credit Ratings at BBB+; Maintains 'Watch Developing' Status
CRISIL Ratings has reaffirmed the credit ratings for Mangalam Organics Limited's bank facilities totaling Rs. 397 Crore. The long-term rating is maintained at CRISIL BBB+ and the short-term rating at CRISIL A2. Both ratings continue to be on 'Rating Watch with Developing Implications', indicating that the credit profile is under close monitoring for potential future changes. The rated facilities include a mix of cash credit, letters of credit, and term loans across several major banks.
முக்கிய அம்சங்கள்
Total bank loan facilities reaffirmed at Rs. 397 CroreLong-term rating maintained at CRISIL BBB+ and short-term at CRISIL A2Ratings continue on 'Rating Watch with Developing Implications' statusMajor facility allocations include Axis Bank (Rs. 125 Cr) and HDFC Bank (Rs. 92.5 Cr)Facilities include Rs. 169.5 Crore in Cash Credit and Rs. 100 Crore in Letters of Credit
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's upcoming financial performance and any news regarding the resolution of the 'Rating Watch' status. While the reaffirmation shows stability, the 'Developing Implications' tag suggests potential volatility in the credit profile.
Mangalam Organics Q3 FY26 Revenue Jumps 32.6% YoY to ₹164.3 Cr; PAT Up 19.6%
Mangalam Organics reported a strong 32.58% YoY revenue growth in Q3 FY26, reaching ₹164.29 crore, driven by volume growth and lower input costs. Net profit for the quarter rose 19.56% to ₹4.34 crore, although margins saw a slight contraction with EBITDA margin at 11.75%. The company successfully completed its Bhimseni/Isoborneol Flakes expansion to 2,500 MTPA in 2025. The retail segment, Mangalam Brands, showed significant EBITDA growth of 252% YoY, contributing ₹55.9 crore to the top line.
முக்கிய அம்சங்கள்
Revenue from operations grew 32.58% YoY to ₹164.29 crore in Q3 FY26.PAT increased by 19.56% YoY to ₹4.34 crore, while full-year FY25 PAT surged 197% to ₹12.50 crore.Successfully completed expansion of Bhimseni/Isoborneol Flakes capacity to 2,500 MT per annum in 2025.Retail subsidiary Mangalam Brands reported a 252% YoY increase in EBITDA to ₹6.9 crore for the quarter.B2B Terpene operations remain the dominant segment, contributing 96% of the company's revenue.
👀 கவனிக்க வேண்டியவை
Investors should monitor the scaling of the newly expanded Bhimseni capacity and the improving profitability of the B2C retail segment. The stock remains a play on pine chemistry and domestic camphor demand, though margin volatility due to raw material costs remains a key risk.
Mangalam Organics Q3 Consolidated Net Profit Rises 19% YoY to ₹4.34 Crore
Mangalam Organics reported a strong consolidated performance for Q3 FY26, with revenue from operations growing 32.6% YoY to ₹164.30 crore. Consolidated net profit increased to ₹4.34 crore from ₹3.64 crore in the same quarter last year, driven by robust subsidiary performance. However, standalone results showed a significant decline in net profit to ₹1.11 crore compared to ₹2.83 crore YoY, indicating margin pressure on the core manufacturing business. The company's consolidated EPS improved to ₹5.07 from ₹4.25 in the year-ago period.
முக்கிய அம்சங்கள்
Consolidated Revenue from Operations grew 32.6% YoY to ₹164.30 crore from ₹123.92 crore.Consolidated Net Profit increased by 19.3% YoY to ₹4.34 crore.Standalone Net Profit declined by 60.8% YoY to ₹1.11 crore, reflecting higher operational costs.Consolidated EPS for the quarter rose to ₹5.07 compared to ₹4.25 in Q3 FY25.Nine-month consolidated profit reached ₹19.76 crore, a significant jump from ₹7.43 crore in the previous year.
👀 கவனிக்க வேண்டியவை
Investors should focus on the consolidated growth which suggests that the company's brand and retail-focused subsidiaries are scaling effectively. Monitor the standalone segment for potential recovery in margins as the core chemical business currently appears to be a drag on overall profitability.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
